Arkin Bio
Status
ACTIVE
Global HQ
Tel Aviv, Israel
Countries of investment
- Israel
- United States
- Canada
- Switzerland
- Germany
Investment stages
- Seed
- Series A
- Series B
- Growth
Industries
- Asset Management
- Public Equities
- Hedge Funds
About
Arkin Bio fuels life sciences breakthroughs as part of Arkin Capital’s multi-stage platform, targeting early- and mid-stage biotech innovation in immunotherapy, novel therapeutics, diagnostics, and digital health, leveraging deep pharmaceutical heritage to scale companies toward global impact.
Arkin Bio fuels life sciences breakthroughs as part of Arkin Capital’s multi-stage platform, targeting early- and mid-stage biotech innovation in immunotherapy, novel therapeutics, diagnostics, and digital health, leveraging deep pharmaceutical heritage to scale companies toward global impact.
Investment Thesis
Arkin Bio fuels biotech and health tech innovation through early-stage venture capital, supporting novel therapeutics, diagnostics, and digital health solutions that accelerate medical progress.
Manager's Experience
Run by long-tenured public market investors with deep expertise in fundamental equity research, portfolio management, and risk-adjusted capital allocation.
Team
Mori Arkin - Founder and Chairman
Nir Arkin - Chief Executive Officer
Portfolio
Keros Therapeutics
HI-Bio
Eleos
Laguna
ARTSaVIT
Metabomed
Oncorus
Pi Therapeutics
Werewolf Therapeutics
BioSight
Bluejay Therapeutics